483 Stason Pharmaceuticals Dec 2013

483 Stason Pharmaceuticals Dec 2013

Caryn Mcnab FDA$119.00 - Available Now

FDA investigators audited the Stason Pharmaceuticals - Irvine, CA, United States facility and issued 6 inspectional observations (via FDA 483) on 18 Dec 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 18 Dec 2013
  • Location: Irvine, United States
  • FEI: 1000160561
Add To Cart